あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/07 | 1,212 | 1,219 | 1,203 | 1,205 | -11 | -0.9% | 44,000 |
| 2022/12/06 | 1,189 | 1,226 | 1,189 | 1,216 | +16 | +1.3% | 73,300 |
| 2022/12/05 | 1,221 | 1,221 | 1,187 | 1,200 | -26 | -2.1% | 76,500 |
| 2022/12/02 | 1,277 | 1,277 | 1,226 | 1,226 | -61 | -4.7% | 86,400 |
| 2022/12/01 | 1,276 | 1,288 | 1,271 | 1,287 | +8 | +0.6% | 56,900 |
| 2022/11/30 | 1,284 | 1,290 | 1,269 | 1,279 | +12 | +0.9% | 58,200 |
| 2022/11/29 | 1,253 | 1,275 | 1,250 | 1,267 | +8 | +0.6% | 51,100 |
| 2022/11/28 | 1,237 | 1,267 | 1,236 | 1,259 | +13 | +1% | 52,800 |
| 2022/11/25 | 1,240 | 1,252 | 1,240 | 1,246 | -1 | -0.1% | 48,200 |
| 2022/11/24 | 1,240 | 1,259 | 1,231 | 1,247 | +17 | +1.4% | 70,800 |
| 2022/11/22 | 1,205 | 1,234 | 1,203 | 1,230 | +27 | +2.2% | 85,400 |
| 2022/11/21 | 1,175 | 1,208 | 1,174 | 1,203 | +38 | +3.3% | 89,300 |
| 2022/11/18 | 1,155 | 1,168 | 1,151 | 1,165 | +16 | +1.4% | 27,800 |
| 2022/11/17 | 1,141 | 1,153 | 1,139 | 1,149 | +4 | +0.3% | 20,600 |
| 2022/11/16 | 1,137 | 1,154 | 1,133 | 1,145 | +8 | +0.7% | 22,200 |
| 2022/11/15 | 1,114 | 1,148 | 1,114 | 1,137 | +23 | +2.1% | 32,300 |
| 2022/11/14 | 1,123 | 1,124 | 1,114 | 1,114 | -7 | -0.6% | 34,900 |
| 2022/11/11 | 1,144 | 1,144 | 1,112 | 1,121 | -2 | -0.2% | 58,900 |
| 2022/11/10 | 1,145 | 1,145 | 1,121 | 1,123 | -27 | -2.3% | 59,300 |
| 2022/11/09 | 1,188 | 1,188 | 1,146 | 1,150 | -33 | -2.8% | 52,900 |
| 2022/11/08 | 1,159 | 1,187 | 1,155 | 1,183 | +36 | +3.1% | 104,200 |
| 2022/11/07 | 1,150 | 1,163 | 1,143 | 1,147 | +9 | +0.8% | 29,900 |
| 2022/11/04 | 1,150 | 1,156 | 1,133 | 1,138 | -14 | -1.2% | 54,500 |
| 2022/11/02 | 1,157 | 1,162 | 1,148 | 1,152 | -10 | -0.9% | 22,000 |
| 2022/11/01 | 1,175 | 1,183 | 1,156 | 1,162 | -10 | -0.9% | 34,200 |
| 2022/10/31 | 1,150 | 1,177 | 1,149 | 1,172 | +37 | +3.3% | 44,700 |
| 2022/10/28 | 1,130 | 1,152 | 1,125 | 1,135 | -6 | -0.5% | 124,500 |
| 2022/10/27 | 1,149 | 1,151 | 1,138 | 1,141 | -13 | -1.1% | 24,700 |
| 2022/10/26 | 1,139 | 1,154 | 1,134 | 1,154 | +18 | +1.6% | 20,100 |
| 2022/10/25 | 1,141 | 1,153 | 1,130 | 1,136 | -3 | -0.3% | 35,700 |
| 2022/10/24 | 1,145 | 1,151 | 1,139 | 1,139 | +1 | +0.1% | 24,700 |
| 2022/10/21 | 1,137 | 1,147 | 1,135 | 1,138 | -8 | -0.7% | 27,700 |
| 2022/10/20 | 1,147 | 1,151 | 1,141 | 1,146 | -21 | -1.8% | 21,800 |
| 2022/10/19 | 1,167 | 1,169 | 1,152 | 1,167 | ±0 | ±0% | 28,300 |
| 2022/10/18 | 1,150 | 1,172 | 1,145 | 1,167 | +11 | +1% | 47,100 |
| 2022/10/17 | 1,168 | 1,168 | 1,154 | 1,156 | -23 | -2% | 25,600 |
| 2022/10/14 | 1,174 | 1,189 | 1,165 | 1,179 | +32 | +2.8% | 44,100 |
| 2022/10/13 | 1,145 | 1,152 | 1,139 | 1,147 | +2 | +0.2% | 36,300 |
| 2022/10/12 | 1,140 | 1,155 | 1,132 | 1,145 | ±0 | ±0% | 33,300 |
| 2022/10/11 | 1,150 | 1,168 | 1,142 | 1,145 | -32 | -2.7% | 37,000 |
| 2022/10/07 | 1,150 | 1,185 | 1,150 | 1,177 | +10 | +0.9% | 36,100 |
| 2022/10/06 | 1,148 | 1,174 | 1,148 | 1,167 | +20 | +1.7% | 36,100 |
| 2022/10/05 | 1,169 | 1,169 | 1,147 | 1,147 | -11 | -0.9% | 31,800 |
| 2022/10/04 | 1,144 | 1,160 | 1,144 | 1,158 | +37 | +3.3% | 43,300 |
| 2022/10/03 | 1,116 | 1,125 | 1,103 | 1,121 | +8 | +0.7% | 26,900 |
| 2022/09/30 | 1,131 | 1,145 | 1,110 | 1,113 | -27 | -2.4% | 37,300 |
| 2022/09/29 | 1,125 | 1,146 | 1,125 | 1,140 | +30 | +2.7% | 81,300 |
| 2022/09/28 | 1,095 | 1,110 | 1,078 | 1,110 | +2 | +0.2% | 90,900 |
| 2022/09/27 | 1,094 | 1,121 | 1,094 | 1,108 | +14 | +1.3% | 37,800 |
| 2022/09/26 | 1,100 | 1,115 | 1,084 | 1,094 | -7 | -0.6% | 56,200 |
651～
700
件表示中 / 1062件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 246,300円 | +16.9% | +33.2% | 2.23% | 13.43倍 | 1.07倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ハートシード | 355,500円 | +174.2% | - | 0.00% | - | 10.76倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ＪＣＲファーマ | 60,000円 | +14.3% | - | 3.33% | 24.39倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ヘリオス | 63,700円 | +150.0% | - | 0.00% | - | 33.79倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| タウンズ | 53,100円 | +4.6% | +6.1% | 5.27% | 9.06倍 | 3.36倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム
